InsidersTradesSigma
PHARMANUTRA PHARMANUTRA S.P.A.: FIRST SIGNIFICANT SALES RESULTS IN CHINA Stock: price and directors' dealings · Italy · Consob
CONSOB:pharmanutra-pharmanutra-spa-first-significant-sales-results-in-china-65c360·ConsobMcap €799.5MHealth Care
Follow the PHARMANUTRA PHARMANUTRA S.P.A.: FIRST SIGNIFICANT SALES RESULTS IN CHINA stock price and the full directors' dealings record of the company, a listed issuer based in Italy. Shares trade on IT IT, under the oversight of Consob. Operating in the Health Care sector, PHARMANUTRA PHARMANUTRA S.P.A.: FIRST SIGNIFICANT SALES RESULTS IN CHINA has recorded 0 public disclosures. Market capitalisation: €799.5m. Every trade is free.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,275 of 28,256 companies
61.8
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.9x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Declarations0 total
No declarations found
0 of 0 declarations
About PHARMANUTRA PHARMANUTRA S.P.A.: FIRST SIGNIFICANT SALES RESULTS IN CHINA
PHARMANUTRA S.P.A. is a company in the health and pharmaceutical sector that recently reported its first significant sales results in China. The company is listed on the XMIL market.